Aspire Biopharma Holdings annual operating expenses
2021
2022
2023
2024
2025
Aspire Biopharma Holdings Operating Expenses Growth & History (ASBP)
Aspire Biopharma Holdings's operating expenses was $19.4M for fiscal 2025.
View full Aspire Biopharma Holdings company overviewAspire Biopharma Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.4M | $18.1M | +1498.12% |
| 2024 | 2024-12-31 | $1.2M | −$129,297 | −9.65% |
| 2023 | 2023-12-31 | $1.3M | $363,823 | +37.26% |
| 2022 | 2022-12-31 | $976,345 | $950,870 | +3732.56% |
| 2021 | 2021-12-31 | $25,475 | — | — |
Aspire Biopharma Holdings quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.6M | $1.8M | +231.06% |
| Q1 2026 | 2026-03-31 | $1.7M | −$13.9M | −89.38% |
| Q4 2025 | 2025-12-31 | $1.8M | $1.2M | +176.83% |
| Q3 2025 | 2025-09-30 | $1.1M | $931,125 | +432.57% |
| Q2 2025 | 2025-06-30 | $799,890 | $702,967 | +725.28% |
| Q1 2025 | 2025-03-31 | $15.6M | $15.3M | +6635.28% |
| Q4 2024 | 2024-12-31 | $667,722 | $265,107 | +65.85% |
| Q3 2024 | 2024-09-30 | $215,256 | −$109,486 | −33.71% |
| Q2 2024 | 2024-06-30 | $96,923 | −$191,323 | −66.37% |
| Q1 2024 | 2024-03-31 | $230,970 | −$93,595 | −28.84% |
| Q4 2023 | 2023-12-31 | $402,615 | $88,586 | +28.21% |
| Q3 2023 | 2023-09-30 | $324,742 | $69,485 | +27.22% |
| Q2 2023 | 2023-06-30 | $288,246 | −$9,594 | −3.22% |
| Q1 2023 | 2023-03-31 | $324,565 | $215,346 | +197.17% |
| Q4 2022 | 2022-12-31 | $314,029 | — | — |
| Q3 2022 | 2022-09-30 | $255,257 | $239,947 | +1567.26% |
| Q2 2022 | 2022-06-30 | $297,840 | $295,457 | +12398.53% |
| Q1 2022 | 2022-03-31 | $109,219 | — | — |
| Q3 2021 | 2021-09-30 | $15,310 | — | — |
| Q2 2021 | 2021-06-30 | $2,383 | — | — |
Aspire Biopharma Holdings operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Aspire Biopharma Holdings's operating expenses increased from $25,475 to $19.4M, a change of $19.3M. The latest reported quarter, Q2 2026, shows $2.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aspire Biopharma Holdings source filings ↗